An anonymous reader quotes a report from NBC News: The Food and Drug Administration on Friday granted a quick review of three experimental psychedelic drugs meant to treat major depression and post-traumatic stress disorder. It's the latest move by the Trump administration signaling a shift in policy toward treatments that also give users a high -- coming a day after the Justice Department said it would ease restrictions on state-licensed medical marijuana. UK-based biotech company Compass Pathways said Friday it has received an expedited review for its experimental form of synthetic psilocybin for treatment-resistant depression. In a press release the company cited two large, phase 3 studies that had "generated positive data." Usona Institute, headquartered in Wisconsin, also said it's received a voucher for its work with psilocybin to treat major depressive disorder. In an email, a Usona spokesperson said the company expects the review process to last one to two months after it submits its application. "The voucher expedites the timeline only; it does not alter scientific or regulatory standards," the spokesperson wrote. New York-based Transcend Therapeutics has also been granted a priority review voucher for its experimental drug methylone for PTSD, Blake Mandell, the company's chief executive officer, said. "There's a battle still raging in their mind that we don't fully understand biochemically," FDA Commissioner Marty Makary said. "When you see something that looks promising for a community that is suffering with mental health illness, despair and suicidal ideation, you can't help but recognize that." Makary told NBC News that with the priority voucher program, the agency could potentially approve the first psychedelic drug by the end of summer.

Read more of this story at Slashdot.

fjo3 shares a report from The Times: More than two-thirds of babies under two use screens, a report has found, and some are exposed for up to eight hours a day. Nearly a third of newborns were found to be watching screens for more than three hours a day, while almost 20 percent of infants of four to 11 months used screens for more than an hour a day. The report comes after the government issued guidance that children under two do not use screens at all, apart from communal activities such as video-calling relatives. In a review of the current research, researchers found evidence linking screen time to poorer outcomes for children, including an increased risk of obesity, short-sightedness, sleep and behavioural difficulties, and later challenges with friendships. [...] The research also revealed why children and parents use screens, with families reporting children doing so for educational purposes, entertainment, play and to communicate and bond with others. Parents, meanwhile, used screens to occupy or distract children, which helped caregivers to complete domestic duties, paid employment and other caring responsibilities. Nearly a quarter of parents -- 23.6 percent -- either had no childcare or were not aware of the government's early years offer.

Read more of this story at Slashdot.

Elon Musk testified on day two of his trial against OpenAI, saying he helped create the company as a nonprofit counterweight to Google and would not have backed it if the goal had been private profit. CNBC reports: Musk on Tuesday was the first witness called to testify in the trial. He spoke about his upbringing, his many companies, his role in founding OpenAI and his understanding of its structure. Musk said in his testimony that he was not opposed to the creation of a small for-profit subsidiary, "as long as the tail didn't wag the dog." Musk said he was motivated to start OpenAI to serve as a counterweight to Google. He got the idea after an argument he had with Google co-founder Larry Page, who called Musk a "speciesist for being pro-human," he testified. "I could have started it as a for profit and I chose not to," Musk said on the stand. Earlier, attorneys for Musk and OpenAI presented their opening arguments to the jury. Musk's lead trial lawyer, Steven Molo, delivered the opening statement for the Tesla and SpaceX CEO. OpenAI lawyer William Savitt gave the opening statement for the AI company, Altman and Brockman. OpenAI has characterized Musk's lawsuit as a baseless "harassment campaign." The company said Monday in a post on X that it "can't wait to make our case in court where both the truth and the law are on our side." During his testimony on Tuesday, Musk repeatedly emphasized that he founded OpenAI to serve as a counterweight to Google. He said he got the idea after an argument about AI safety with Google co-founder Larry Page, who Musk said called him "a speciesist for being pro-human." Musk said he was concerned Page was not taking AI safety seriously, so he wanted there to be an nonprofit, open source alternative to Google. "I could have started it as a for profit and I chose not to," Musk said on the stand. Further reading: Elon Musk and OpenAI CEO Sam Altman Head To Court

Read more of this story at Slashdot.